- Home
- EVTL vs MREO Comparison
EVTL vs MREO Comparison
Compare EVTL & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVTL
- MREO
- Stock Information
- Founded
- EVTL 2016
- MREO 2015
- Country
- EVTL United Kingdom
- MREO United Kingdom
- Employees
- EVTL N/A
- MREO N/A
- Industry
- EVTL Aerospace
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- EVTL Industrials
- MREO Health Care
- Exchange
- EVTL Nasdaq
- MREO Nasdaq
- Market Cap
- EVTL 467.9M
- MREO 438.8M
- IPO Year
- EVTL N/A
- MREO N/A
- Fundamental
- Price
- EVTL $6.98
- MREO $1.77
- Analyst Decision
- EVTL Strong Buy
- MREO Strong Buy
- Analyst Count
- EVTL 7
- MREO 5
- Target Price
- EVTL $10.83
- MREO $7.20
- AVG Volume (30 Days)
- EVTL 2.3M
- MREO 4.2M
- Earning Date
- EVTL 08-05-2025
- MREO 08-12-2025
- Dividend Yield
- EVTL N/A
- MREO N/A
- EPS Growth
- EVTL N/A
- MREO N/A
- EPS
- EVTL N/A
- MREO N/A
- Revenue
- EVTL N/A
- MREO N/A
- Revenue This Year
- EVTL N/A
- MREO N/A
- Revenue Next Year
- EVTL N/A
- MREO $51.92
- P/E Ratio
- EVTL N/A
- MREO N/A
- Revenue Growth
- EVTL N/A
- MREO N/A
- 52 Week Low
- EVTL $2.76
- MREO $1.57
- 52 Week High
- EVTL $15.99
- MREO $5.02
- Technical
- Relative Strength Index (RSI)
- EVTL 61.00
- MREO 32.95
- Support Level
- EVTL $4.69
- MREO $1.57
- Resistance Level
- EVTL $5.10
- MREO $3.05
- Average True Range (ATR)
- EVTL 0.49
- MREO 0.16
- MACD
- EVTL 0.02
- MREO -0.11
- Stochastic Oscillator
- EVTL 78.81
- MREO 15.88
About EVTL Vertical Aerospace Ltd.
Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero operating emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).